166 related articles for article (PubMed ID: 22180837)
1. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.
Huet T; Maehr H; Lee HJ; Uskokovic MR; Suh N; Moras D; Rochel N
Medchemcomm; 2011; 2(5):424-429. PubMed ID: 22180837
[TBL] [Abstract][Full Text] [Related]
2. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
[TBL] [Abstract][Full Text] [Related]
3. Novel Gemini analogs of 1alpha,25-dihydroxyvitamin D(3) with enhanced transcriptional activity.
Weyts FA; Dhawan P; Zhang X; Bishop JE; Uskokovic MR; Ji Y; Studzinski GP; Norman AW; Christakos S
Biochem Pharmacol; 2004 Apr; 67(7):1327-36. PubMed ID: 15013848
[TBL] [Abstract][Full Text] [Related]
4. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
5. Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor.
Eelen G; Valle N; Sato Y; Rochel N; Verlinden L; De Clercq P; Moras D; Bouillon R; Muñoz A; Verstuyf A
Chem Biol; 2008 Oct; 15(10):1029-34. PubMed ID: 18940664
[TBL] [Abstract][Full Text] [Related]
6. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
Bury Y; Herdick M; Uskokovic MR; Carlberg C
J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
[TBL] [Abstract][Full Text] [Related]
7. Diastereotopic and deuterium effects in gemini.
Maehr H; Rochel N; Lee HJ; Suh N; Uskokovic MR
J Med Chem; 2013 May; 56(10):3878-88. PubMed ID: 23566225
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol derivatives with two different side chains at C-20. 24-hydroxy derivatives as metabolic products and molecular probes for VDR exploration.
Maehr H; Uskokovic MR; Reddy GS; Adorini L
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):35-8. PubMed ID: 15225743
[TBL] [Abstract][Full Text] [Related]
9. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.
Lin Z; Marepally SR; Kim TK; Janjetovic Z; Oak AS; Postlethwaite AE; Myers LK; Tuckey RC; Slominski AT; Miller DD; Li W
Anticancer Res; 2016 Mar; 36(3):877-86. PubMed ID: 26976974
[TBL] [Abstract][Full Text] [Related]
11. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.
Belorusova AY; Suh N; Lee HJ; So JY; Maehr H; Rochel N
J Steroid Biochem Mol Biol; 2017 Oct; 173():69-74. PubMed ID: 27650654
[TBL] [Abstract][Full Text] [Related]
13. Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.
Sakamaki Y; Inaba Y; Yoshimoto N; Yamamoto K
J Med Chem; 2010 Aug; 53(15):5813-26. PubMed ID: 20608741
[TBL] [Abstract][Full Text] [Related]
14. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
Lee HJ; Paul S; Atalla N; Thomas PE; Lin X; Yang I; Buckley B; Lu G; Zheng X; Lou YR; Conney AH; Maehr H; Adorini L; Uskokovic M; Suh N
Cancer Prev Res (Phila); 2008 Nov; 1(6):476-84. PubMed ID: 19138995
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini.
Maehr H; Uskokovic MR; Adorini L; Reddy GS
J Med Chem; 2004 Dec; 47(26):6476-84. PubMed ID: 15588082
[TBL] [Abstract][Full Text] [Related]
16. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
17. Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling.
Lee HJ; So JY; DeCastro A; Smolarek A; Paul S; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):408-12. PubMed ID: 20304052
[TBL] [Abstract][Full Text] [Related]
18. A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects.
Huet T; Laverny G; Ciesielski F; Molnár F; Ramamoorthy TG; Belorusova AY; Antony P; Potier N; Metzger D; Moras D; Rochel N
Cell Rep; 2015 Feb; 10(4):516-26. PubMed ID: 25620699
[TBL] [Abstract][Full Text] [Related]
19. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
Ciesielski F; Rochel N; Moras D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket.
Molnár F; Peräkylä M; Carlberg C
J Biol Chem; 2006 Apr; 281(15):10516-26. PubMed ID: 16478719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
